In this study, we examined the capacity of a biomimetic pullulan–collagen hydrogel to create
a functional biomaterial-based stem cell niche for the delivery of mesenchymal stem cells …

Adipose-derived mesenchymal stem cells (ASCs) are appealing for cell-based wound
therapies because of their accessibility and ease of harvest, but their utility is limited by poor …

Mesenchymal stem cells (MSCs) have been shown to improve tissue regeneration in
several preclinical and clinical trials. These cells have been used in combination with three …

Effective skin regeneration therapies require a successful interface between progenitor cells
and biocompatible delivery systems. We previously demonstrated the efficiency of a …

Mesenchymal stem cells (MSCs) secrete endogenous factors such as vascular endothelial
growth factor (VEGF) and prostaglandin E2 (PGE 2) that promote angiogenesis, modulate …

The aim of this study was to design a dermal substitute containing adipose derived stem
cells (ADSC) that can be used to improve the regeneration of skin on difficult wound beds by …

The therapeutic efficacy of clinically applied mesenchymal stromal cells (MSCs) is limited
due to their injection into harsh in vivo environments, resulting in the significant loss of their …

The nonhematopoietic component of bone marrow includes multipotent mesenchymal stem
cells (MSC) capable of differentiating into fat, bone, muscle, cartilage, and endothelium. In …

Stem cell therapies are limited by poor cell survival and engraftment. A hurdle to the use of
materials for cell delivery is the lack of understanding of material properties that govern …

The purpose of this study was to permit bone marrow mesenchymal stem cells (BMSCs) to
reach their full potential in the treatment of chronic wounds. A biocompatible multifunctional …